Gut Bacteria Keep Time, and Disrupting Their Rhythm May Destabilize Artery Plaques
A new review argues that disrupted day-night cycles in gut microbes may make arterial plaques prone to rupture, and proposes timing-based therapies to resync them.
Resumo
Heart attacks and strokes cluster in the early morning, and β-blockers only trim that peak by about 30%. This narrative review argues that gut microbiota, which follow their own daily rhythm, may help explain the rest. When feeding schedules or the host's body clock are disrupted (for example by shift work or jet lag), microbial metabolites such as short-chain fatty acids shift out of phase. That may impair endothelial function, dysregulate immune cells and fuel plaque inflammation, pushing plaques toward rupture. The authors propose 'Chronotherapy-based Microbiome Modulation' (CMM): time-restricted feeding, time-specific probiotics and clock-targeting drugs to realign host and microbial rhythms. The idea is promising but still largely hypothetical, with most evidence coming from animal and mechanistic studies.
Resumo Detalhado
Why it matters: Acute coronary events follow a strong daily pattern. About 35–40% of acute coronary syndrome events occur between 6:00 and 12:00, and coronary stent thrombosis peaks near 7:00. Blood pressure surges, sympathetic activation and platelet reactivity are the usual explanations. Yet blocking sympathetic activity with β-blockers reduces the morning peak by only about 30%. The authors suggest that the gut microbiota, which oscillates on a roughly 24-hour cycle and is sometimes called the host's 'second clock', may be an overlooked contributor to the timing of plaque rupture.
What was studied: This is a narrative review (about 140 references), not a new experiment. It synthesizes mostly preclinical and mechanistic literature on three questions. How do the host circadian clock and microbial rhythms regulate each other? How might disrupted microbial rhythms destabilize atherosclerotic plaques through a 'metabolic-immune-vascular' network? Can timing-based interventions restore synchrony? The full text available for this summary ends early in the mechanisms section, so the later intervention and translation material is summarized from the abstract.
Key points: The regulation runs both ways. Core clock genes (BMAL1, CLOCK, PER/CRY) shape microbial composition and function through feeding behavior, bile acid secretion and gut motility. Bmal1-deficient mice and shift-work-mimicking mice lose rhythmicity in short-chain fatty acid (SCFA) fermentation and lipid metabolism. Light can influence microbial homeostasis through circadian control of intestinal ILC3 immune cells. In the other direction, microbes drive rhythmic expression of epithelial HDAC3 and the transcription factor NFIL3, which affect metabolic gene activity, nutrient absorption and energy metabolism. Microbial functions are also time-partitioned: DNA repair and energy metabolism are more active at night, while detoxification, motility and environmental sensing dominate in the day. Erratic eating can shift these phases and produce mismatched metabolite output and immune regulation. Disrupted rhythms are proposed to harm plaques through dysregulated SCFA signaling (GPCR activation, histone deacetylase inhibition), endothelial dysfunction, abnormal lipid deposition and heightened macrophage-driven inflammation. The authors describe a vicious cycle of metabolic imbalance, immune disorder and vascular damage.
Implications: The authors propose Chronotherapy-based Microbiome Modulation (CMM). It combines time-restricted feeding or intermittent fasting, probiotics given at specific times, and drugs targeting the circadian clock to realign host and microbial rhythms and stabilize plaques. They identify hurdles for clinical translation: predicting personalized dosing or feeding windows, assessing the ecological risks of altering the microbiota, and using multi-omics monitoring with AI modeling to guide treatment.
Caveats: The causal chain from microbial rhythm disruption to human plaque rupture is largely inferred from animal and mechanistic data. CMM is a conceptual framework with no demonstrated clinical benefit yet. The review is narrative rather than systematic, so selection bias is possible, and the authors themselves note that the specific mechanisms still need elucidation.
Principais Descobertas
- About 35–40% of acute coronary syndrome events occur between 6:00 and 12:00, and β-blockers cut the early-morning peak by only roughly 30%.
- Host clock genes (BMAL1, CLOCK, PER/CRY) shape microbial rhythms; Bmal1-deficient and shift-work mice lose rhythmic SCFA fermentation and lipid metabolism.
- Microbes in turn drive rhythmic intestinal HDAC3 and NFIL3 expression, linking microbial timing to host metabolic gene activity and energy handling.
- Disordered eating can shift microbial functional phases, mistiming SCFA output and immune regulation, with proposed endothelial, lipid and plaque-inflammation consequences.
- The authors propose Chronotherapy-based Microbiome Modulation, using time-restricted feeding, timed probiotics and clock-targeting drugs, though it remains untested clinically.
Metodologia
Narrative review of about 144 references synthesizing mainly preclinical and mechanistic studies on host clock-microbiota interactions and plaque biology. No formal systematic search, quality appraisal or meta-analysis is described. The provided full text was truncated early in the mechanisms section, so later sections are summarized from the abstract.
Limitações do Estudo
Most supporting evidence comes from animal models and mechanistic studies, and causality in human plaque rupture is unproven. Being a narrative review, it may reflect selective citation, and CMM itself is a conceptual framework without clinical trial data. Practical hurdles include individual variability in microbial rhythms, optimal timing windows and the ecological risks of manipulating the microbiota.
Gostou deste resumo?
Receba as pesquisas de longevidade mais recentes na sua caixa de entrada toda semana.
Digite seu e-mail para assinar:
